tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
NervGen Pharma (TSE:NGEN)
:NGEN
Canadian Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports

NervGen Pharma (NGEN) Stock News & Sentiment

Compare
62 Followers
NervGen Pharma Lists on Nasdaq to Support Late-Stage Push for Spinal Cord Injury Drug
Premium
Company Announcements
NervGen Pharma Lists on Nasdaq to Support Late-Stage Push for Spinal Cord Injury Drug
3d ago
NervGen Pharma Files SEC Registration to Advance Strategic Growth
Premium
Company Announcements
NervGen Pharma Files SEC Registration to Advance Strategic Growth
24d ago
NervGen Pharma Proposes Amendment to Warrant Terms
Premium
Company Announcements
NervGen Pharma Proposes Amendment to Warrant Terms
29d ago
NervGen Pharma Advances NVG-291 for Spinal Cord Injury Treatment
Premium
Company Announcements
NervGen Pharma Advances NVG-291 for Spinal Cord Injury Treatment
2M ago
NervGen Pharma’s NVG-291 Shows Promising Results in Spinal Cord Injury Treatment
Premium
Company Announcements
NervGen Pharma’s NVG-291 Shows Promising Results in Spinal Cord Injury Treatment
2M ago
NervGen Pharma Secures $10M to Propel Nasdaq Listing and NVG-291 Development
Premium
Company Announcements
NervGen Pharma Secures $10M to Propel Nasdaq Listing and NVG-291 Development
2M ago
NervGen Pharma Secures $10 Million to Propel Nasdaq Listing and NVG-291 Development
Premium
Company Announcements
NervGen Pharma Secures $10 Million to Propel Nasdaq Listing and NVG-291 Development
2M ago
More TSE:NGEN News >

NGEN News on the Web

NervGen Pharma Debuts On Nasdaq
rttnews
Neutral
NervGen Pharma (NGENF) Receives a Buy from Stifel Nicolaus
TipRanks News
Neutral
NervGen Provides Quarterly "At-The-Market" Equity Program Update | NGENF Stock News
GuruFocus News
Neutral
NervGen Pharma to Host Virtual Event on Spinal Cord Injury Treatment
TipRanks News
Neutral
NervGen Pharma Grants Stock Options
Yahoo Finance
Neutral
NervGen Pharma to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Yahoo Finance
Neutral
Buy Rating on NervGen Pharma Backed by Strong Market Potential and Early Positive Trial Results
TipRanks News
Bullish
NervGen Advances Spinal Injury Drug, Secures Funds
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
TSE:NGEN
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average59%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:NGEN’s Media Buzz Sentiment?
1 articles about TSE:NGEN were published this week. In an average week, 1 articles are published.
    What is TSE:NGEN’s weekly average amount of articles?
    In an average week, 1 articles about TSE:NGEN are published.
      What is TSE:NGEN’s News Sentiment?
      50% of articles about TSE:NGEN were positive this week, compared to its sector average of 59%.
        Healthcare Stocks that are Trending in the News
        RVMDRevolution Medicines
        REGNRegeneron
        KRYSKrystal Biotech
        GNPXGenprex
        RIGLRigel
        Showing the stocks with the most bullish news sentiment over the past week